Modulation of the proteolytic balance plasminogen activator/plasminogen activator inhibitor by enhanced N-myc oncogene expression or application of genistein
- 1 October 1998
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (11) , 1736-1740
- https://doi.org/10.1016/s0959-8049(98)00285-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cellsPublished by Elsevier ,2004
- 1992 MACK FORSTER AWARD LECTURE REVIEWEuropean Journal of Clinical Investigation, 1992
- Chlorpheniramine inhibits the ornithine decarboxylase induction of Ehrlich carcinoma growing in vivoFEBS Letters, 1992
- Identification in human urine of a natural growth inhibitor for cells derived from solid paediatric tumoursEuropean Journal of Clinical Investigation, 1992
- The latent tendencies of PAI-1Trends in Biochemical Sciences, 1992
- Tumor-Associated Urokinase-Type Plasminogen Activator: Biological and Clinical SignificanceBiological Chemistry Hoppe-Seyler, 1992
- The plasminogen activator/plasmin system.Journal of Clinical Investigation, 1991
- Plasminogen activator inhibitorsTrends in Cardiovascular Medicine, 1991
- Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogeneCell, 1990
- The Relevance of Plasminogen Activators to Neoplastic GrowthEnzyme, 1988